Study protocol: systematic review and meta-analysis of randomized controlled trials in first-line treatment of squamous non-small cell lung cancer

Схожие документы

• First-line treatment of patients with advanced or metastatic squamous non-small cell lung cancer: systematic review and network meta-analysis
  по: Hess, Lisa M., et al.
  Опубликовано: (2018)
• Nimotuzumab plus chemotherapy and immunotherapy as first-line/neoadjuvant therapy for advanced esophageal squamous cell carcinoma
  по: Qi Wang, et al.
  Опубликовано: (2025-07-01)
• Effectiveness of first-line treatments in metastatic squamous non-small-cell lung cancer
  по: Levy, B.P., et al.
  Опубликовано: (2019)
• Combination of first-line chemotherapy with Kanglaite injections versus first-line chemotherapy alone for advanced non-small-cell lung cancer: study protocol for an investigator-initiated, multicenter, open-label, randomized controlled trial
  по: Gao, Ruike, et al.
  Опубликовано: (2021)
• PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma
  по: Buckley, Hannah L., et al.
  Опубликовано: (2019)